Prethy Rao

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study”.

Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study

Journal of Clinical Investigation(2024)10.1172/jci180916

N/A

0.332DataRank · unranked

8 citations

Dan Spiegelman, Prethy Rao, Andria L. Ford, Jonathan J. Miner, Rajendra S. Apte +1 more

Reactivation of Retinopathy of Prematurity in Adults and Adolescents

Ophthalmology Retina(2020)10.1016/j.oret.2020.02.001

N/A

0DataRank · unranked

24 citations

Prethy Rao, G. Baker Hubbard, Ogul E. Uner

Risk Factors for Retinal Detachment in Acute Retinal Necrosis

Ophthalmology Retina(2022)10.1016/j.oret.2022.01.016

N/A

0DataRank · unranked

25 citations

Casey Anthony, Aaron Lindeke-Myers, Stephanie Lynch, Lucy T. Xu, Joshua M. Barnett +13 more

Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity

Ophthalmology(2022)10.1016/j.ophtha.2022.05.019

N/A

0DataRank · unranked

27 citations

Amra Hercinovic, David K. Wallace, Raymond T. Kraker, Zhuokai Li, Amit Bhatt +79 more